The Testing

Consortium Credentials & Logistics

The COVID Consortium’s high complexity molecular diagnostic laboratory utilize industry leading equipment including the latest real-time PCR technologies from Roche, ThermoFisher, Fluidigm and other diagnostic tools that have been approved under the Emergency Use Authorization (EUA) guidance issued by the FDA as well as CAP¹ ,COLA² and CLIA³ quality standards.  Our laboratory’s SARS-CoV-2 testing has been given FDA EUA Approval.

The CopernicusMD platform supports a comprehensive solution to manage the complex and scale-able laboratory testing services for the SARS-CoV-19 Screening Test under proprietary technology and a premier team of licensed, experienced physicians, scientists and lab directors.

Consortium Capability

CopernicusMD’s proprietary platform technology and algorithm increases lab testing and efficiency by utilizing capacity and capability driven decisions for commercial testing across multiple service points in Real-Time:

CopernicusMD’s proprietary platform technology and algorithm increases lab testing and efficiency by utilizing capacity and capability driven decisions for commercial testing across multiple service points in Real-Time:
Testing allocated based on our real-time capacity capability
Uniformity created in process and access for all stakeholders
Single point accountability for test tracking
Centralized specimen accessioning allows all project stakeholders access to testing from specimen collection to resulting
Informs stakeholders of problem specimens in real-time
Allows for all stakeholders to receive results in real-time
Communication with patients and stakeholders for managing post Covid diagnosis testing.

College of American Pathologists
Commission of Office Laboratory Accreditation
Clinical Laboratory Improvement Amendments